About Company
- Legal Name: Molsyns Research
- Registered country: India
- Address: 134, Swetayan Industrial Estate, Kathwada-Singarva Rd, opp. Bahuchar Party Plot,, Kathwada • Gujarat
- Number of employees: 50 - 99
- Established year: 2018
Description:
Molsyns Research is a contract research and development organization (CRDO) started in 2019 by experienced scientists with a customer-centric approach. Located in Ahmedabad, the company's experienced team specializes in the custom synthesis of complex organic compounds for use as reference standards by pharmaceutical industries around the world.
Business Activities
Contract Research Organisations Services (CROs)
Clinical Trial Organization
Laboratory Chemicals, Solvents & Reference Standards
Custom Synthesis Provider
Laboratory & Analytical Services
Contract ManufacturerTesting LaboratoryClinical Trial Organization
Innovator APIs
Contract ManufacturerClinical Trial OrganizationTesting Laboratory
Contract & Outsourcing Services
Testing LaboratoryContract ManufacturerClinical Trial Organization
Pharma Chemicals
Testing LaboratoryClinical Trial OrganizationContract Manufacturer
Sales Markets
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
Key Products/Services
- Contract & Outsourcing Services: Custom Synthesis, Fosfomycin
- Laboratory Chemicals, Solvents & Reference Standards: Impurity Standard Set, Pharmaceutical Reference Standards, Isotope-labelled reference standards, Metabolites, Drug glucuronides
- Biological & Fermentation Ingredients: Custom Peptide Synthesis
- Pharma Chemicals: Focused compound libraries, Custom synthesis of complex organic compounds
- Contract Research Organisations Services (CROs): R&D Research and Development
- Innovator APIs: Semaglutide, Amino Acids
Our Products & Services
Offer Service · Contract & Outsourcing Services
Certifications
Proofs
CPHI India 2026
11/2026 – 11/2026
CPHI India 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment